Segment Evaluation and Major Growth Areas in the RNA Sequencing Services Market

The RNA sequencing services market is set to experience significant expansion in the coming years, driven by advancements in precision medicine and increasing demand for detailed transcriptomic insights. This sector's growth is shaped by technological innovations and rising integration of AI tools, making it a critical area of focus within genomic research and pharmaceutical development. Let's explore the current market valuation, the leading players, prevailing trends, and the key market segments defining this dynamic industry.

Projected Growth and Market Size of RNA Sequencing Services
The RNA sequencing services market is expected to witness strong growth, reaching a valuation of $6.38 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 9.5%. The anticipated rise is linked to several factors such as the growing adoption of precision medicine techniques, increased demand for transcriptomic data in clinical diagnostics, expansion of pharmaceutical research and development, wider use of AI-driven analytics, and a higher tendency to outsource sequencing services. Key market trends during this period include escalating demand for high-throughput transcriptome analysis, broader adoption of next-generation sequencing (NGS)-based RNA sequencing, enhanced bioinformatics integration, increased utilization in clinical research, and a stronger focus on improving data accuracy and reproducibility.

Download a free report of the rna sequencing services market report:
https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Leading Companies Driving the RNA Sequencing Services Market
Several prominent companies play a vital role in shaping the RNA sequencing services landscape. These include Thermo Fisher Scientific Inc., Illumina Inc., Qiagen NV, BGI Genomics Co Ltd, Azenta Inc., Novogene Co Ltd, Genewiz Inc., Diagenode LLC, CD Genomics, CeGaT GmbH, Lexogen GmbH, BaseClear BV, Active Motif Inc., Microsynth AG, Genomax Technologies Pte Ltd, Creative Biogene, SeqMatic LLC, Genohub Inc., Otogenetics, LC Sciences, Admera Health, Arraystar Inc., IGA Technology, Yaazh Xenomics, and Novaseq Services Ltd.

Enhancements through Strategic Acquisitions in RNA Sequencing
In January 2024, Parse Biosciences, a US-based life sciences company, acquired Biomage Ltd., a UK-based firm specializing in RNA sequencing data analysis and genomic research, for an undisclosed sum. This acquisition aims to strengthen Parse Biosciences' capabilities in single-cell RNA sequencing data analysis, enabling faster and deeper insights for genomic research and precision medicine. The move highlights ongoing efforts to enhance analytical tools and services within the RNA sequencing market.

View the full rna sequencing services market report:
https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Automation and Advanced Assays Shaping RNA Sequencing Trends
A major trend within the RNA sequencing market is the focus on automation to minimize human error and improve both efficiency and data precision. Next-generation sequencing (NGS) assays, in particular, are becoming essential tools for molecular biology and genomics research. For example, in June 2023, Tempus, a US-based precision medicine technology company, launched its new RNA NGS assay called Tempus xR. This assay offers comprehensive transcriptome analysis for solid tumors, detecting clinically relevant fusions in over 100 targeted genes and identifying altered splicing events such as MET Exon 14 and EGFRvIII. Tempus has historically combined RNA and DNA sequencing in its broad-panel xT assay, but now clients can order RNA and DNA tests independently or together, with options to add specific Tempus algorithmic tests. This flexibility benefits clinicians, researchers, and biopharma organizations seeking detailed RNA fusion and splicing data.

Detailed Market Segments of the RNA Sequencing Services Industry
The RNA sequencing services market is broadly segmented as follows:
1) By Type: Ribosomal RNA (rRNA), Transfer RNA (tRNA), Long non-coding RNA (lncRNA)
2) By Sequencing Method: Next Generation Sequencing Methods, Other Sequencing Methods
3) By Application: Research Purposes, Diagnostic Purposes
4) By End Users: Academic and Government Institutes and Research Centers, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Other End Users

Further subcategories include:
- Ribosomal RNA (rRNA): Total rRNA Sequencing and rRNA Depletion
- Transfer RNA (tRNA): tRNA Profiling and tRNA Sequencing
- Long non-coding RNA (lncRNA): lncRNA Profiling and lncRNA Sequencing

These classifications offer a comprehensive understanding of the market's scope and specialization areas.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.